12:00 AM
Feb 18, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Myriad Genetics, Saladax sales and marketing update

Saladax said Myriad will return North American rights to its My5-FU diagnostic test following a pipeline evaluation. Saladax said Myriad, which had marketed...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >